The federal government and the two groups that sued it separately to force it to issue long delayed 340B administrative dispute resolution (ADR) regulations agreed last night to keep stays in place in both lawsuits until Jan. 3, 2022. Meanwhile, drug manufacturer AstraZeneca is seeking a stay in one set of ADR proceedings and the panel assigned to hear another set of ADR proceedings has issued a scheduling order.